Acorah Software Products - Accounts Production 16.8.200 false true false true No description of principal activity 21 January 2025 31 January 2026 31 January 2026 16198919 Mrs Darina Holmes Dr Michael Holmes iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 16198919 2025-01-20 16198919 2026-01-31 16198919 2025-01-21 2026-01-31 16198919 frs-core:CurrentFinancialInstruments 2026-01-31 16198919 frs-bus:PrivateLimitedCompanyLtd 2025-01-21 2026-01-31 16198919 frs-bus:FilletedAccounts 2025-01-21 2026-01-31 16198919 frs-bus:Micro-entities 2025-01-21 2026-01-31 16198919 frs-bus:AuditExemptWithAccountantsReport 2025-01-21 2026-01-31 16198919 frs-bus:Director1 2025-01-21 2026-01-31 16198919 frs-bus:Director2 2025-01-21 2026-01-31
Registered number: 16198919
Holmes Darcy Pharma Consulting Ltd
Unaudited Financial Statements
For the Period 21 January 2025 to 31 January 2026
Accountwise Ltd
Holmes Darcy Pharma Consulting Ltd
Accountant's Report
For the Period 21 January 2025 to 31 January 2026
Accountant's Report
Chartered Accountant's report to the directors on the preparation of the unaudited statutory accounts of Holmes Darcy Pharma Consulting Ltd for the period 21 January 2025 to 31 January 2026
In order to assist you to fulfil your duties under the Companies Act 2006, I have prepared for your approval the accounts of Holmes Darcy Pharma Consulting Ltd for the period 21 January 2025 to 31 January 2026 which comprise the Profit and Loss Account, the Balance Sheet and the related notes from the company's accounting records and from information and explanations you have given to us.
As a practising member of the Institute of Chartered Accountants in England and Wales (ICAEW), we are subject to its ethical and other professional requirements which are detailed at http://www.icaew.com/en/membership/regulations-standards-and-guidance.
This report is made solely to the directors of Holmes Darcy Pharma Consulting Ltd , as a body, in accordance with the terms of our engagement letter dated 27 June 2025. Our work has been undertaken solely to prepare for your approval the accounts of Holmes Darcy Pharma Consulting Ltd and state those matters that we have agreed to state to the directors of Holmes Darcy Pharma Consulting Ltd , as a body, in this report in accordance with ICAEW Technical Release 07/16 AAF. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than Holmes Darcy Pharma Consulting Ltd and its directors, as a body, for our work or for this report.
It is your duty to ensure that Holmes Darcy Pharma Consulting Ltd has kept adequate accounting records and to prepare statutory accounts that give a true and fair view of the assets, liabilities, financial position and profit or loss of Holmes Darcy Pharma Consulting Ltd . You consider that Holmes Darcy Pharma Consulting Ltd is exempt from the statutory audit requirement for the period.
We have not been instructed to carry out an audit of the accounts of Holmes Darcy Pharma Consulting Ltd . For this reason, we have not verified the accuracy or completeness of the accounting records or information and explanations you have given to us and we do not, therefore, express any opinion on the financial statements.

02/03/2026

Accountwise Ltd
198 Finchampstead Road
Wokingham
Berkshire
RG40 3HB
Page 1
Holmes Darcy Pharma Consulting Ltd
Balance Sheet
As At 31 January 2026
Balance Sheet
Registered number: 16198919

| 31 January 2026
--- | ---
|  | £
Current assets |  | 33,848
Creditors: Amounts Falling Due Within One Year |  | (9,658 )
NET CURRENT ASSETS |  | 24,190
TOTAL ASSETS LESS CURRENT LIABILITIES |  | 24,190
NET ASSETS |  | 24,190
CAPITAL AND RESERVES |  | 24,190

## Notes

1. General Information
Holmes Darcy Pharma Consulting Ltd is a private company, limited by shares, incorporated in England & Wales, registered number 16198919 . The registered office is 71-75 Shelton Street, Covent Garden, London, WC2H 9JQ.
2. Average Number of Employees
Average number of employees, including directors, during the period was: 2
2
For the period ending 31 January 2026 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
On behalf of the board

Mrs Darina Holmes Director | Dr Michael Holmes Director
02/03/2026